British Thoracic Society guidelines on diagnostic flexible bronchoscopy

Thorax

Volumn 56, Issue SUPPL. 1, 2001, Pages

  Honeybourne, D ^a   Babb, J ^b   Bowie, P ^c   Brewin, A ^d   Fraise, A ^b   Garrard, C ^e   Harvey, J ^f   Lewis, R ^g   Neumann, C ^b   Wathen, C G ^h   Williams, T ^c  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c KETTERING GENERAL HOSPITAL   (United Kingdom)

^d KENT AND SUSSEX HOSPITAL   (United Kingdom)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f SOUTHMEAD HOSPITAL   (United Kingdom)

^g WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^h WYCOMBE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTARALDEHYDE; LIDOCAINE; LOCAL ANESTHETIC AGENT; OXYGEN;

ANALGESIA; ANESTHESIA; ATYPICAL MYCOBACTERIUM; BRONCHOSCOPY; DISINFECTION; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; HOSPITAL INFECTION; HUMAN; INFORMATION PROCESSING; INSTRUMENT STERILIZATION; INTENSIVE CARE; MEDICAL STAFF; OCCUPATIONAL ASTHMA; OCCUPATIONAL SAFETY; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEDATION; STAFF TRAINING; THORAX DISEASE; WASTE MANAGEMENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; DISEASE TRANSMISSION; DRUG ADMINISTRATION; DRUG CONTRAINDICATION; EQUIPMENT; LUNG DISEASE; METHODOLOGY; MONITORING; PATIENT SELECTION; PROTECTIVE CLOTHING; STANDARD;

ANESTHETICS, LOCAL; ANTIBIOTIC PROPHYLAXIS; BRONCHOSCOPY; DATA COLLECTION; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DISINFECTION; DRUG ADMINISTRATION SCHEDULE; EQUIPMENT CONTAMINATION; HUMANS; INTENSIVE CARE; LIDOCAINE; LUNG DISEASES; MONITORING, PHYSIOLOGIC; OXYGEN; PATIENT SELECTION; PROTECTIVE CLOTHING;

EID: 18844464904     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.56.suppl_1.i1     Document Type: Review

References (219)

1. Bronchoscopy and infection control
2. Guidelines for care during bronchoscopy: British Thoracic Society
3. Diagnostic fiberoptic bronchoscopy: Techniques and results of biopsy in 600 patients
4. Complications of fiberoptic bronchoscopy
5. Deaths and complications associated with fiberoptic bronchoscopy
6. Postal survey of bronchoscopic practice by physicians in the United Kingdom
7. Flexible fibreoptic bronchoscopy in the teaching hospital
8. A prospective cooperative study of complications following flexible fiberoptic bronchoscopy
9. Complications of fiberoptic bronchoscopy at a university hospital
10. Complications of bronchoscopy. Comparison of rigid bronchoscopy under general anesthesia and flexible fiberoptic bronchoscopy under topical anesthesia
11. Complications following fiberoptic bronchoscopy
12. Transbronchial biopsy via flexible fibroptic bronchoscope: Results in 164 patients
13. Pulmonary haemorrhage in fibreoptic transbronchial biopsy
14. Patient comfort and plasma lignocaine concentrations during fibreoptic bronchoscopy
15. Is fibreoptic bronchoscopy in patients with lung cancer and hepatic metastases potentially dangerous?
16. Serum concentrations of lignocaine and its metabolite monoethylglycinexylidide during fibreoptic bronchoscopy in local anaesthesia
17. Serum lidocaine concentrations in asthmatics undergoing research bronchoscopy
18. Hypoxemia during fiberoptic bronchoscopy
19. Alterations in pulmonary mechanics and gas exchange during routine fiberoptic bronchoscopy
20. Bronchoalveolar lavage: Comparison of three commonly used procedures
21. Pulse oximetry during fibreoptic bronchoscopy in local anaesthesia: Frequency of hypoxaemia and effect of oxygen supplementation
22. Pulse oximetry at fibreoptic bronchoscopy in local anaesthesia: Indication for postbronchoscopy oxygen supplementation?
23. Changes in oxygen saturation and transcutaneous carbon dioxide and oxygen levels in patients undergoing fibreoptic bronchoscopy
24. Noninvasive positive-pressure ventilation via face mask during bronchoscopy with BAL in high-risk hypoxemic patients
25. Arrhythmias from fiberoptic bronchoscopy
26. The effect of fiberoptic bronchoscopy on cardiac rhythm
27. Effects of diagnostic procedures during fiberoptic bronchoscopy on heart rate, blood pressure, and blood gases
28. Myocardial ischemia in sedated patients undergoing fiberoptic bronchoscopy
29. Arrhythmias in patients with heart disease during fiberoptic bronchoscopy
30. Cardiac arrhythmias. Frequency during fiberoptic bronchoscopy and correlation with hypoxemia
31. Bronchoscopy induced bleeding: A summary of nine years Cleveland Clinic experience and review of the literature
32. Transbronchial lung biopsy with the fibreoptic bronchoscope: Analysis of results in 433 patients
33. Complications in transbronchial lung biopsy
34. The effect of forceps size on the adequacy of specimens obtained by transbronchial biopsy
35. Safety and yield of transbronchial biopsy in mechanically ventilated patients
36. Flexible bronchoscopy
37. Transbronchial biopsy in the thrombocytopenic patient
38. Do "screening" coagulation tests predict bleeding in patients undergoing fiberoptic bronchoscopy with biopsy?
39. Transbronchial biopsy in the presence of profound elevation of the international normalized ratio (INR)
40. Guidelines on oral anticoagulation: Third edition
41. Fiberoptic bronchoscopy in local anaesthesia. Indications, results and complications in 1323 examinations
42. Transbronchial forceps lung biopsy through the fiberoptic bronchoscope. Diagnosis of diffuse pulmonary disease
43. Transbronchial biopsy without fluoroscopy: A five year experience in outpatients
44. Bronchial and transbronchial lung biopsy without fluoroscopy in sarcoidosis
45. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults
46. The safety, of outpatient transbronchial biospy
47. Delayed pneumothorax after transbronchial lung biopsy
48. Sepsis syndrome and death after bronchoalveolar lavage
49. Bronchoalveolar lavage: Performance, sampling procedure, processing and assessment
50. Cytokines derived from alveolar macrophages induce fever after bronchoscopy and bronchoalveolar lavage
51. Incidence of fever and bacteremia following transbronchial needle aspiration
52. A study to assess the efficacy of chemoprophylaxis in the prevention of endoscopy-related bacteraemia in patients aged 60 and over
53. Fibreoptic bronchoscopy and the use of antibiotic prophylaxis
54. Incidence of bacteraemia following fibreoptic bronchoscopy
55. Prevention of infective endocarditis
56. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
57. Serious infectious complications after flexible fibreoptic bronchoscopy
58. Recommendations for endocarditis prophylaxis
59. An audit of bronchoscopy practice in the United Kingdom: A survey of adherence to national guidelines
60. Report of a working party, on the staffing of endoscopy units
61. Cardiovascular consequences of fibreoptic bronchoscopy
62. Analysis of the safety of bronchoscopy after recent acute myocardial infarction
63. Fibreoptic bronchoscopy in coronary care unit patients
64. Fiberoptic bronchoscopy after recent acute myocardial infarction. Stress for the heart?
65. Is it really safe to perform bronchoscopy after a recent acute myocardial infarct?
66. Guidelines for peri-operative cardiovascular evaluation for non cardiac surgery
67. Complications in the fiber bronchoscopy of bronchial asthma patients
68. Effects of inhaled lidocaine on airway function in asthmatic subjects
69. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma
70. Safety of bronchoalveolar lavage and bronchial biopsies in patients with asthma of variable severity
71. Bronchoalveolar lavage. Its safety in subjects with mild asthma
72. Complications of flexible bronchoscopy in patients with severe obstructive pulmonary disease
73. Fibreoptic bronchoscopy in the elderly: 4 year's experience
74. Safety, usefulness and acceptability of fibreoptic bronchoscopy in the elderly
75. The effect of fiberoptic bronchoscopy on cerebral hemodynamics in patients with severe head injury
76. Fiberoptic bronchoscopy in the presence of space-occupying intracranial lesions
77. Clinical efficacy of early and delayed fiberoptic bronchoscopy in patients with hemoptysis
78. Utility of fiberoptic bronchoscopy in patients with hemoptysis and a nonlocalizing chest roentgenogram
79. Patients prefer sedation for fibreoptic bronchoscopy
80. Patient satisfaction with conscious sedation for bronchoscopy
81. Common fears of patients undergoing bronchoscopy
82. Fibreoptic bronchoscopy: Is sedation necessary?
83. Fiberoptic bronchoscopy without pre-medication. A retrospective study
84. Bronchoscopy in North America: The ACCP survey
85. Preparation of the patient for awake flexible fiberoptic bronchoscopy
86. Does sedation help in fibreoptic bronchoscopy?
87. Sedation in fibreoptic bronchoscopy. Further study is needed
88. Premedication for fibreoptic bronchoscopy
89. Safety and patient acceptability of intravenous midazolam for fibre optic bronchoscopy
90. Fiberoptic bronchoscopy in the intensive care unit: A prospective study of 147 procedures in 107 patients
91. Sedation for fibre optic bronchoscopy
92. A randomized, doubleblind, placebo-controlled study of lorazepam as premedication for bronchoscopy
93. Prolonged midazolam elimination half-life
94. Comparison of diazepam and midazolam for sedation during local anaesthesia for bronchoscopy
95. Comparison of midazolam with propofol for sedation in outpatient bronchoscopy
96. Alfentanil used to supplement propofol infusions for oesophagoscopy and bronchoscopy
97. Sedation for bronchofiberoscopy: Comparison between propofol infusion and intravenous boluses of fentanyl and diazepam
98. A comparative evaluation of propofol and midazolam as sedative agents in fiberoptic bronchoscopy
99. Sedation for fibreopfic bronchoscopy
100. Nalbuphine combined with midazolam for outpatient sedation. An assessment in fibreoptic bronchoscopy patients
101. Local anaesthesia for fibreoptic bronchoscopy: Comparison between cocaine and lignocaine
102. Topical nasal anaesthesia for fibreoptic bronchoscopy: Patients' preference for lignocaine gel
103. Plasma concentrations of lignocaine during fibreoptic bronchoscopy
104. Topical anaesthesia of the nasal mucosa for fibreoptic airway endoscopy
105. A jet nebuliser for delivery of topical anesthesia to the respiratory tract. A comparison with cricothyroid puncture and direct spraying for fibreoptic bronchoscopy
106. Local anaesthesia for fibreoptic bronchoscopy: Transcricoid injection or the "spray as you go" technique?
107. Comparison of three different methods used to achieve local anesthesia for fiberoptic bronchoscopy
108. Anticholinergic premedication for fibreoptic bronchoscopy
109. The role of atropine pre-medication in fiberoptic bronchoscopy using intravenous midazolam sedation
110. Atropine as premedication for anaesthesia and bronchoscopy
111. Cleaning and disinfection of equipment for gastrointestinal endoscopy. Report of a working party of the British Society of Gastroenterology Endoscopy Committee
112. Decontamination of urological equipment. Interim report of a Working Group of the Standing Committee on Urological Instruments of the British Association of Urological Surgeons
113. APIC guidelines for infection prevention and control in flexible endoscopy
114. Disinfection and endoscopy: Summary and recommendations
115. Transmission of infection by gastrointestinal endoscopy and bronchoscopy
116. Nosocomial infections associated with endoscopy
117. Endoscope decontamination: Where do we go from here?
118. Fever and pneumonia after flexible fibreoptic bronchoscopy
119. Fibreoptic bronchoscopic related outbreaks of infection with pseudomonas
120. Pseudomonas aeruginosa contamination of fibreoptic bronchoscopes
121. Outbreaks of Serratia marcescens associated with flexible fiber bronchoscopes
122. An outbreak of pulmonary-pseudoinfection by Serraria marcescens
123. Contamination of a fibreoptic bronchoscope with a Proteus species
124. Pseudoepidemic of Legionella pneumophila serogroup 6 associated with contaminated bronchoscopes
125. Mycobacteria and AIDS
126. Disinfecting endoscopes: How not to transmit Mycobacterium tuberculosis by bronchoscopy
127. Transmission of tuberculosis by flexible fiber bronchoscopes
128. Transmission of Mycobacterium tuberculosis by a fibreoptic bronchoscope: Identification of DNA finger printing
129. Transmission of a highly drug-resistant strain (W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope
130. Contamination of flexible fibreoptic bronchoscopes
131. Mycobacterium chelonae isolation from bronchoalveolar lavage fluid and its practical implications
132. Cross contamination of bronchial washings
133. Mycobacterial contamination of fibreoptic bronchoscopes
134. Glutaraldehyde resistant Mycobacterium chelonae from endoscope washer disinfectors
135. Mycobacterial resistance to disinfection in AIDS: Whither infection control practices now?
136. Mycobactericidal testing of disinfectants: An update
137. Endoscopic transmission of hepatitis B virus
138. Patient to patient transmission of hepatitis C virus during colonoscopy
139. Contamination of endoscopes used in AIDS patients
140. Pseudo-outbreak of Bacillus spores related to fibreoptic bronchoscopy
141. A pseudo-epidemic of pulmonary fungal infections related to fibreoptic bronchoscopy
142. AIDS: Practising safe endoscopy
143. An outbreak of hepatitis A among health care workers: Risk factors for transmission
144. Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: Probable transmission via hands of a health care worker
145. Chemotherapy and management of tuberculosis in the United Kingdom
146. Health risks through airborne allergens for patients presensitised to latex
147. Surgical latex gloves bind latex antigens
148. Glove powder: A risk factor for the development of latex allergy?
149. Personal respiratory protection against Mycobacterium tuberculosis
150. Control of nosocomial transmission of multi-drug resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients
151. Aldehyde disinfectants and health in endoscopy units. Report of a British Society of Gastroenterology Working Party
152. Fiberoptic bronchoscopy in ventilated patients. Evaluation of cardiopulmonary risk under midazolam sedation
153. The value of fiberoptic bronchoscopy in the management of pulmonary collapse
154. Acute lobar atelectasis: A prospective comparison of fiberoptic bronchoscopy and respiratory therapy
155. Treatment for collapsed lung in critically ill patients. Selective intrabronchial air insufflation using the fiberoptic bronchoscope
156. Fiberoptic bronchoscopy in the intensive care unit
157. Bilateral bronchoalveolar lavage in the diagnosis of opportunistic pulmonary infections
158. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: A pilot study
159. Mortality of nosocomial pneumonia in ventilated patients: Influence of diagnostic tools
160. Safety of bronchoalveolar lavage in the critically ill, mechanically ventilated patient
161. Transbronchial biopsy during mechanical ventilation
162. Seizure after lidocaine for bronchoscopy: Case report and review of the use of lidocaine in airway anaesthesia
163. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome
164. A computerised bronchoscopy database providing reporting and auditing facilities
165. An analysis of the first: 33 fibreoptic bronchoscopies at the Brompton hospital
166. The Scottish multi-centre prospective study of bronchoscopy for bronchial carcinoma and suggested audit standards
167. Guidelines for competency and training in fiberoptic bronchoscopy
168. An epidemic of pseudomembranous laryngotracheitis
169. The measurement of patient satisfaction
170. Patient expectations and satisfaction with health care
171. Patient satisfaction with conscious sedation for endoscopy
172. Music improves patient comfort level during outpatient bronchoscopy
173. Introducing a music program in the perioperative area
174. Macmillan nurses: Fighting cancer with more than medicine
175. Development and evaluation of written patient information endoscopic procedures
176. Patient education: Pre-teaching the bronchoscopy patient: Ignorance isn't bliss
177. Answers to your questions on bronchscopy
178. Inpatient education for fibreoptic/videoptic diagnostic and therapeutic procedures for gastroenterology
179. Current theory and practice: A study of pre-operative fasting
180. Drinking before sedation
181. Preoperative drinking does not affect gastric contents
182. Enabling patients to make informed decisions
183. Consent to treatment: What value consent forms?
184. Informed consent for bronchoscopy
185. Value of washings and brushings at fibreoptic bronchoscopy in the diagnosis of lung cancer
186. Fibreoptic bronchoscopy: Effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma
187. Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy
188. Scottish national bronchoscopy audit: A prospective multicentre study of 3316 cases against agreed standards
189. Bronchial needle aspiration in the diagnosis of bronchial carcinoma
190. Transbronchial needle aspiration in the diagnosis of submucosal and peribronchial bronchogenic carcinoma
191. The role of transcarinal needle aspiration in the staging of brochogenic carcinoma
192. Comparison of the Wang 19-gauge and 22-gauge needles in the mediasrinal staging of lung cancer
193. Comparison of standard and enlarged forceps for transbronchiai lung biopsy in the diagnosis of lung infiltrates
194. Transbronchial lung biopsy: An analysis of 530 cases with reference to the number of samples
195. Technical recommendations and guidelines for broncho-alveolar lavage (BAL). Report of the European Society of Pneumonolgy Task Group on BAL
196. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis and selected comparison groups
197. Endoscope decontamination: Automated versus manual
198. National Health Service Estates